UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Confocal Raman Spectral Imaging Study of DAPT, a γ-secretase Inhibitor, Induced Physiological and Biochemical Reponses in Osteosarcoma Cells

International journal of medical sciences, 2020-01, Vol.17 (5), p.577-590

2020

Volltextzugriff (PDF)

Saxagliptin in type 2 diabetes

Drugs of Today, 2010-02, Vol.46 (2), p.101-108

Billiones, Raquel

2010

Volltextzugriff (PDF)

Saxagliptin + metformin. Mostly disadvantages

Prescrire international, 2013-02, Vol.22 (135), p.40-40

2013

Volltextzugriff (PDF)

Saxagliptin and tuberculosis

Prescrire international, 2013-01, Vol.22 (134), p.17-17

2013

Volltextzugriff (PDF)

T Cell Repertoire Complexity Is Conserved after LLME Treatment of Donor Lymphocyte Infusions

Biology of blood and marrow transplantation, 2007-12, Vol.13 (12), p.1439-1447

2007

Volltextzugriff (PDF)

Saxagliptin. No more effective than other gliptins, but a high potential for drug interactions

Prescrire international, 2011-02, Vol.20 (113), p.33-37

2011

Volltextzugriff (PDF)

Comparative effects of different antihypertensive treatments on progression of diabetic renal disease

Archives of internal medicine (1960), 1993-04, Vol.153 (8), p.973

1993

Volltextzugriff (PDF)

Effect of adamantylamide dipeptide on reinfection resistance after primary infection eradication in experimental Schistosomiasis mansoni

Arzneimittel-Forschung, 1996-01, Vol.46 (1), p.74

1996

Volltextzugriff (PDF)

Angiotensin converting enzyme inhibitors and rheumatoid arthritis

Arthritis and rheumatism, 1985-04, Vol.28 (4), p.480-480

1985

Volltextzugriff (PDF)

Acute effects of a pseudo-tetrapeptide as renin inhibitor on blood pressure and renin-angiotensin system of sodium-repleted and sodium-depleted hypertensive patients

Arzneimittel-Forschung, 1993-02, Vol.43 (2A), p.255

1993

Volltextzugriff (PDF)

Hypertensive crisis in systemic sclerosis: treatment with the new oral angiotensin converting enzyme inhibitor mk 421 (enalapril) in captopril‐intolerant patients

Arthritis and rheumatism, 1984-07, Vol.27 (7), p.826-828

1984

Volltextzugriff (PDF)

Experimental liver damage in potassium depletion, inhibited by L-ornithine-L-aspartate

Arzneimittel-Forschung, 1971-10, Vol.21 (10), p.1620

Raab, W P

1971

Volltextzugriff (PDF)

Cool reception for drug to limit smoking damage

New scientist (1971), 2003-10, Vol.180 (2415), p.11-11

Cohen, Philip

2003

Volltextzugriff (PDF)

The astrocyte surface NAAG receptor and NAAG peptidase signaling complex as a therapeutic target

Drug News & Perspectives, 2008-06, Vol.21 (5), p.251

Baslow, Morris H

2008

Volltextzugriff (PDF)

Molecule of the month. Talabostat

Drug news & perspectives, 2006-06, Vol.19 (5), p.299-299

2006

Volltextzugriff (PDF)

Hypotensive and hemodynamic effects of the new non-sulfhydryl angiotensin converting enzyme inhibitor N-[8-amino-1(S)-carboxyoctyl]-L-alanyl-L-proline

Arzneimittel-Forschung, 1990-12, Vol.40 (12), p.1303

1990

Volltextzugriff (PDF)

Study on the reduction of chemotherapy induced neutropenia in mice using glucosaminylmuramyl dipeptide

Arzneimittel-Forschung, 1999-08, Vol.49 (8), p.716-720

1999

Volltextzugriff (PDF)

Antihypertensive properties of a new long-acting angiotensin converting enzyme inhibitor in renin-dependent and independent hypertensive models

Arzneimittel-Forschung, 1995-08, Vol.45 (8), p.853

1995

Volltextzugriff (PDF)

1 – 18 von 18

Suche als RSS-Feed

Aktive Filter

Nur zeigenGeprüft (Peer-Review)

ThemaAged

KollektionPublisher website

SpracheEnglisch

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Mit Volltextzugriff
(7)

Publikationsform

Artikel
(17)
magazinearticle
(1)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Confocal Raman Spectral Imaging Study of DAPT, a γ-secretase Inhibitor, Induced Physiological and Biochemical Reponses in Osteosarcoma Cells

Saxagliptin in type 2 diabetes

Saxagliptin + metformin. Mostly disadvantages

Saxagliptin and tuberculosis

T Cell Repertoire Complexity Is Conserved after LLME Treatment of Donor Lymphocyte Infusions

Saxagliptin. No more effective than other gliptins, but a high potential for drug interactions

Comparative effects of different antihypertensive treatments on progression of diabetic renal disease

Effect of adamantylamide dipeptide on reinfection resistance after primary infection eradication in experimental Schistosomiasis mansoni

Angiotensin converting enzyme inhibitors and rheumatoid arthritis

Acute effects of a pseudo-tetrapeptide as renin inhibitor on blood pressure and renin-angiotensin system of sodium-repleted and sodium-depleted hypertensive patients

Hypertensive crisis in systemic sclerosis: treatment with the new oral angiotensin converting enzyme inhibitor mk 421 (enalapril) in captopril‐intolerant patients

Experimental liver damage in potassium depletion, inhibited by L-ornithine-L-aspartate

Cool reception for drug to limit smoking damage

The astrocyte surface NAAG receptor and NAAG peptidase signaling complex as a therapeutic target

Molecule of the month. Talabostat

Hypotensive and hemodynamic effects of the new non-sulfhydryl angiotensin converting enzyme inhibitor N-[8-amino-1(S)-carboxyoctyl]-L-alanyl-L-proline

Study on the reduction of chemotherapy induced neutropenia in mice using glucosaminylmuramyl dipeptide

Antihypertensive properties of a new long-acting angiotensin converting enzyme inhibitor in renin-dependent and independent hypertensive models

Aktive Filter

Suchergebnisse filtern